![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Alzheimer's Disease |
Free Subscription
1 Acta Neuropathol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Alzheimer's Disease is free of charge.
Correction: Pyroptosis in Alzheimer's disease: cell type?specific activation in
microglia, astrocytes and neurons.
Acta Neuropathol. 2024;149:3.
PubMed
A whole-brain functional connectivity model of Alzheimer's disease pathology.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14349.
PubMed
Abstract available
Accelerated ovarian failure results in brain alterations related to Alzheimer's
disease that are not recovered by high-intensity interval training in mice.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14463.
PubMed
Abstract available
Diagnostic accuracy of phosphorylated tau217 in detecting Alzheimer's disease
pathology among cognitively impaired and unimpaired: A systematic review and
meta-analysis.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14458.
PubMed
Abstract available
Factors associated with care-resistant behavior in the National Alzheimer's
Coordinating Center's Uniform Data Set.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14451.
PubMed
Abstract available
Premenopausal bilateral oophorectomy and Alzheimer's disease imaging biomarkers
later in life.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14469.
PubMed
Abstract available
Differences in baseline cognitive performance between participants with
early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14218.
PubMed
Abstract available
Lewy body co-pathology in Alzheimer's disease and primary age-related tauopathy
contributes to differential neuropathological, cognitive, and brain atrophy
patterns.
Alzheimers Dement. 2024 Dec 22. doi: 10.1002/alz.14191.
PubMed
Abstract available
Sex and APOE epsilon4 allele differences in longitudinal white matter microstructure in
multiple cohorts of aging and Alzheimer's disease.
Alzheimers Dement. 2024 Dec 22. doi: 10.1002/alz.14343.
PubMed
Abstract available
Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical
trials.
Alzheimers Dement. 2024 Dec 22. doi: 10.1002/alz.14321.
PubMed
Abstract available
Centiloid recommendations for clinical context-of-use from the AMYPAD consortium.
Alzheimers Dement. 2024;20:9037-9048.
PubMed
Abstract available
The pathogenicity of PSEN2 variants is tied to Abeta production and homology to
PSEN1.
Alzheimers Dement. 2024;20:8867-8877.
PubMed
Abstract available
Additive effects of cerebrovascular disease functional connectome phenotype and
plasma p-tau181 on longitudinal neurodegeneration and cognitive outcomes.
Alzheimers Dement. 2024;20:8739-8757.
PubMed
Abstract available
The ADNI Administrative Core: Ensuring ADNI's success and informing future AD
clinical trials.
Alzheimers Dement. 2024;20:9004-9013.
PubMed
Abstract available
Thorase deficiency causes both Abeta accumulation and tau hyperphosphorylation in
mouse brain.
Alzheimers Dement. 2024;20:8769-8786.
PubMed
Abstract available
Cerebrovascular markers of WMH and infarcts in ADNI: A historical perspective and
future directions.
Alzheimers Dement. 2024;20:8953-8968.
PubMed
Abstract available
Sex-specific topological structure associated with dementia via latent space
estimation.
Alzheimers Dement. 2024;20:8387-8401.
PubMed
Abstract available
Genome-wide transcriptome analysis of Abeta deposition on PET in a Korean cohort.
Alzheimers Dement. 2024;20:8787-8801.
PubMed
Abstract available
Global brain activity and its coupling with cerebrospinal fluid flow is related
to tau pathology.
Alzheimers Dement. 2024;20:8541-8555.
PubMed
Abstract available
Technology that CARES: Enhancing dementia care through everyday technologies.
Alzheimers Dement. 2024;20:8969-8978.
PubMed
Abstract available
Latent change-on-change between amyloid accumulation and cognitive decline.
Alzheimers Dement. 2024;20:8728-8738.
PubMed
Abstract available
A short version of the Everyday Cognition scale can predict clinical progression
and cognitive decline.
Alzheimers Dement. 2024;20:8651-8660.
PubMed
Abstract available
Enrichment for clinical trials of early AD: Combining genetic risk factors and
plasma p-tau as screening instruments.
Alzheimers Dement. 2024;20:8484-8502.
PubMed
Abstract available
Microscopy assessment of a fluorescence [(18)F] flortaucipir analog (T726) shows
neuropathological overlap with 3R and 4R tau lesions.
Alzheimers Dement. 2024;20:8758-8768.
PubMed
Abstract available
Biomarker pathway heterogeneity of amyloid-positive individuals.
Alzheimers Dement. 2024;20:8503-8515.
PubMed
Abstract available
APOE ?4-related blood-brain barrier breakdown is associated with microstructural
abnormalities.
Alzheimers Dement. 2024;20:8615-8624.
PubMed
Abstract available
LEAP! Rx: A randomized trial of a pragmatic approach to lifestyle medicine.
Alzheimers Dement. 2024;20:8374-8386.
PubMed
Abstract available
Evaluating the updated LATE-NC staging criteria using data from NACC.
Alzheimers Dement. 2024;20:8359-8373.
PubMed
Abstract available
Precision diagnosis of cognitive impairment due to Alzheimer's disease for
therapeutic interventions.
Alzheimers Dement. 2024 Dec 24. doi: 10.1002/alz.14043.
PubMed
Abstract available
The Alzheimer's Association clinical practice guideline for the Diagnostic
Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease
and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for
specialty care.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14337.
PubMed
Abstract available
Alzheimer's Association clinical practice guideline for the Diagnostic
Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease
and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for
primary care.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14333.
PubMed
Abstract available
The Alzheimer's Association clinical practice guideline for the diagnostic
evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease
and related disorders (DETeCD-ADRD): Validated clinical assessment instruments.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14335.
PubMed
Abstract available
Association of APOE alleles and polygenic profiles comprising APOE-TOMM40-APOC1
variants with Alzheimer's disease neuroimaging markers.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14445.
PubMed
Abstract available
Integrating rare pathogenic variant prioritization with gene-based association
analysis to identify novel genes and relevant multimodal traits for Alzheimer's
disease.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14444.
PubMed
Abstract available
Plasma Abeta(42)/Abeta(40) is sensitive to early cerebral amyloid accumulation and
predicts risk of cognitive decline across the Alzheimer's disease spectrum.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14442.
PubMed
Abstract available
Longitudinal cognitive performance of participants with sporadic early onset
Alzheimer's disease from LEADS.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14439.
PubMed
Abstract available
Neuropathological correlates of vulnerability and resilience in the cerebellum in
Alzheimer's disease.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14428.
PubMed
Abstract available
Stabilization of mitochondria-associated endoplasmic reticulum membranes
regulates Abeta generation in a three-dimensional neural model of Alzheimer's
disease.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14417.
PubMed
Abstract available
Proteomic signatures of Alzheimer's disease and Lewy body dementias: A
comparative analysis.
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14375.
PubMed
Abstract available
Alzheimer's Association's funding portfolio: Insights from the International
Alzheimer's and Related Dementias Research Portfolio (IADRP).
Alzheimers Dement. 2024 Dec 23. doi: 10.1002/alz.14354.
PubMed
Abstract available
A Multiform Heterogeneity Framework for Alzheimer's Disease Based on Multimodal
Neuroimaging.
Biol Psychiatry. 2024 Dec 24:S0006-3223(24)01817.
PubMed
Abstract available
A fatal familial insomnia patient initially misdiagnosed as Alzheimer's disease:
a case report.
BMC Neurol. 2024;24:489.
PubMed
Abstract available
Inhibition of autophagy attenuates cognitive decline and mitochondrial
dysfunction in an Alzheimer's disease mouse model with chronic cerebral
hypoperfusion.
Brain Res. 2024;1850:149416.
PubMed
Abstract available
Exploring the Therapeutic Potential of 8-Prenyldaidzein: A Comprehensive Study of
its Multi-Target Efficacy in Alzheimer's Disease.
Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050358848241211080546.
PubMed
Abstract available
The Relationship between Alzheimer's Disease and Ferroptosis: A Bibliometric
Study Based on Citespace.
Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050348799241211072746.
PubMed
Abstract available
Acetyl-L-Carnitine Aids in Preservation of Cholinergic Neurons and Memory in the
Drosophila melanogaster Model of Alzheimer's Disease.
Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050347906241203075930.
PubMed
Abstract available
Apathy Associated with Alzheimer's Disease.
Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050350970241216072400.
PubMed
Abstract available
Recent Updates on Alzheimer's Disease: Pathogenesis, Pathophysiology, Molecular
Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate
Disease.
Curr Alzheimer Res. 2024 Dec 23. doi: 10.2174/0115672050361294241211071813.
PubMed
Abstract available
Impacts of adapted dance on mood and physical function among persons living with
Alzheimer's disease.
J Alzheimers Dis. 2024 Dec 23:13872877241298529. doi: 10.1177/13872877241298529.
PubMed
Abstract available
Alzheimer's disease prediction and prevention in a public health perspective:
Ethical considerations and collaborations beyond the biomedical paradigm.
J Alzheimers Dis. 2024 Dec 23:13872877241308299. doi: 10.1177/13872877241308299.
PubMed
Abstract available
The updated prevalence and risk factors of dementia in old adults in China: A
cross-sectional study.
J Alzheimers Dis. 2024;102:1209-1223.
PubMed
Abstract available
Higher CSF sTREM2 attenuates APOE epsilon4-related risk for amyloid pathology in
cognitively intact adults: The CABLE study.
J Neurochem. 2025;169:e16273.
PubMed
Abstract available
Erratum: Tosi et al., "The Network Structure of Cognitive Impairment: From
Subjective Cognitive Decline to Alzheimer's Disease".
J Neurosci. 2024 Dec 23:e2082242024. doi: 10.1523/JNEUROSCI.2082-24.2024.
PubMed
Patient- and Caregiver-Reported Impact of Symptoms in Alzheimer Disease, Mild
Cognitive Impairment, and Dementia.
Neurol Clin Pract. 2025;15:e200418.
PubMed
Abstract available
Comparison of Plasma p-tau217 and [(18)F]FDG-PET for Identifying Alzheimer
Disease in People With Early-Onset or Atypical Dementia.
Neurology. 2025;104:e210211.
PubMed
Abstract available
Multimodal feature fusion-based graph convolutional networks for Alzheimer's
disease stage classification using F-18 florbetaben brain PET images and clinical
indicators.
PLoS One. 2024;19:e0315809.
PubMed
Abstract available
Thank you for your interest in scientific medicine.